Tenax Therapeutics, Inc.
TENX· Nasdaq
TENXTenax Therapeutics, Inc.
Released Nov 12, 2025, after the close
10-Q filed Nov 12, 2025, 43 days after period end · 0001193125-25-277793
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $0.00 | — | — | — |
| Net Income | -$15.80M | -$3.96M | $1.97M | $2.92M |
| EPS Diluted |
Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR
| -$0.40 |
| -$0.19 |
| — |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
